AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Jun 4, 2025
35599_dirs_2025-06-04_3df388d6-6436-4259-869f-50b59a2c8855.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-06-03
Reporting Person: RALLIS CHRIS A (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-03 | Stock Option | $7.88 | A | 20000 | Acquired | 2035-06-03 | Common shares (20000) | Direct |
Footnotes
F1: On June 3, 2025, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2: The option is 100% vested on date of grant.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20